<PAGE> 1
FORM 10-QSB/A
(Amendment No. 1)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
(Mark One)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1996
-----------------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
-------------- ---------------
Commission file number 0-16257
------------------
Pace Medical, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Massachusetts 04-2867416
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) identification No.)
391 Totten Pond Road, Waltham, Massachusetts 02154
--------------------------------------------------
(Address of principal executive offices )
(617) 890-5656
----------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
----- -----
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all documents
and reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court. Yes No
----- -----
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of May 15, 1996.
3,391,770 shares of Common Stock, par value $.01 per share
<PAGE> 2
PART II - OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits: 27. Financial Data Schedule
(b) Reports on Form 8-K: None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PACE MEDICAL, INC.
-------------------------------
(Registrant)
Date: June 25, 1996 /s/ RALPH E. HANSON
------------ -------------------------------
Ralph E. Hanson, President
and Principal Executive Officer
Date: June 25, 1996 /s/ RALPH E. HANSON
------------ -------------------------------
Ralph E. Hanson, Principal
Financial Officer
-2-
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S.
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> MAR-31-1996
<EXCHANGE-RATE> 1
<CASH> 825,647
<SECURITIES> 0
<RECEIVABLES> 514,765
<ALLOWANCES> 0
<INVENTORY> 503,842
<CURRENT-ASSETS> 1,896,443
<PP&E> 48,189
<DEPRECIATION> 0
<TOTAL-ASSETS> 1,967,483
<CURRENT-LIABILITIES> 427,501
<BONDS> 0
<COMMON> 1,528,988
0
0
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 1,967,483
<SALES> 597,081
<TOTAL-REVENUES> 597,081
<CGS> 308,598
<TOTAL-COSTS> 308,598
<OTHER-EXPENSES> 165,462
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 131,025
<INCOME-TAX> 0
<INCOME-CONTINUING> 131,025
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 131,025
<EPS-PRIMARY> .04
<EPS-DILUTED> .04
</TABLE>
